Dementia and Alzheimer's Disease: Could plant-based Traditional Chinese Medicines aid treatment?

By Gary Scattergood

- Last updated on GMT

Dementia and Alzheimer's Disease: Could plant-based Traditional Chinese Medicines aid treatment?

Related tags Medicine

A new study of classical Chinese medical texts has found almost 1500 references to age-related memory impairment similar to Alzheimer's disease, and to several plant-based ingredients that should be assessed further for their treatment potential today.

Charlie Xue and coauthors from Guangdong Provincial Academy of Chinese Medical Sciences and Guangdong Provincial Hospital of Chinese Medicine, China, and RMIT University, Australia, performed a comprehensive, systematic search of the Encyclopedia of Traditional Chinese Medicine, a database of more than 1,000 Chinese medical books dating back to the fourth century.

In the article "Memory Impairment, Dementia and Alzheimer's Disease in Classical and Contemporary Traditional Chinese Medicine”,​ the authors describe specific mentions of signs and symptoms of memory impairment associated with ageing and the formulas and ingredients most commonly used to treat these disorders.

They note that Alzheimer’s Disease is a significant and increasing health issue in China and other Asian countries. Traditional medicines are commonly used in China for prevention and/or treatment of dementia, and it is a growing field of academic research.

The study sates: “The selection criteria identified 1498 citations of dementia and memory impairments derived from 277 different books written from circa 363 to 1945. In 91 of these citations, memory impairment was associated with ageing and was broadly consistent with the clinical features of Alzheimer’s Disease.

“Although the interventions varied in name, Poria cocos, Polygala tenuifolia, Rehmannia glutinosa, Panax ginseng, and Acorus species consistently appeared as ingredients in multiple formulas for memory impairment in the context of ageing.”

While researchers point out that historical use alone does not provide evidence that any of the traditional medicines were effective for memory impairment or Alzheimer’s Disease, they suggest experimental studies of the five most common and/or their constituents suggest benefits are plausible. 

“P. ginsenghas improved cognitive outcomes in some clinical trials,”​ they write. “In rats with experimentally induced memory impairment, the ginsenosides Rg1 and Rg5 improved memory and task performance ​and the ginsenosides Rg1, Rg3, and Rg5 have all demonstrated down regulatory effects on beta-amyloid. The compound catalpol from R. glutinosa has shown neuroprotective effects in cells treated with beta-amyloid, and it may be able to increase the synthesis of neurotransmitter acetylcholine.”

Classical formulas

Meanwhile an extract of P. tenuifolia​ was reported to protect neurones from damage by beta-amyloid, ​and in cognitively impaired mice, a triterpenoid saponin from Polygala​ roots improved learning and memory.

Furthermore, “the combination of Polygala, Acorus, and Poriaspecies showed antioxidant functions and improved learning in memory-impaired mice,”​ they add.

They suggest these and other traditional medicines may provide fertile fields for research into interventions for the management of memory impairments and Alzheimer’s disease.

“Many of the traditional medicines frequently used as ingredients in classical formulas for memory impairment consistent with clinical features of Alzheimer’s disease remain in contemporary use, and experimental studies suggest biological activities relevant to Alzheimer’s disease,”​ they concluded.

Source: The Journal of Alternative and Complementary Medicine

Volume: 22 Issue 9: September 1, 2016. doi:10.1089/acm.2016.0070

“Memory Impairment, Dementia, and Alzheimer's Disease in Classical and Contemporary Traditional Chinese Medicine”
Authors: Charlie Xue, et al​.

Related news

Show more

Related products

show more

Healthy ageing: a food supplement from Biofarma Group

Healthy ageing: a food supplement from Biofarma Group

Content provided by Biofarma Group | 26-Feb-2024 | White Paper

Worldwide, the percentage of people over 65 and 80 years of age is steadily increasing. However, as society continues to age, people do not necessarily...

Nootropics Report 2.0: Brain Health Insights

Nootropics Report 2.0: Brain Health Insights

Content provided by dsm-firmenich | 20-Feb-2024 | Insight Guide

The brain health market is constantly growing and evolving, with more consumers looking for innovative ways to support total mind and body wellness.

Related suppliers

Follow us

Products

View more

Webinars